Geron elects Patricia S. Andrews and Constantine Chinoporos to board

GERON CORP

Patricia S. Andrews and Constantine Chinoporos elected as Class III directors effective March 25, 2026.
Andrews appointed to Audit Committee; terms expire at 2026 Annual Meeting.
Andrews is former CEO of Sumitomo Pharma Oncology and global head of oncology.
Chinoporos served as COO/CBO at Applied Therapeutics and Albireo Pharmaceuticals.
Both will receive standard non-employee director compensation and indemnification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.